MEDP
Medpace Holdings IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$11.70B
P/E Ratio
25.78
EPS
$15.89
Beta
1.39
52W High
$628.92
52W Low
$284.10
50-Day MA
$468.70
200-Day MA
$510.97
Dividend Yield
—
Profit Margin
17.20%
Forward P/E
24.33
PEG Ratio
2.52
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.
Fundamentals
| Revenue (TTM) | $2.68B |
| Gross Profit (TTM) | $1.93B |
| EBITDA | $591.01M |
| Operating Margin | 20.00% |
| Return on Equity | 77.20% |
| Return on Assets | 17.50% |
| Revenue/Share (TTM) | $94.44 |
| Book Value | $16.18 |
| Price-to-Book | 19.55 |
| Price-to-Sales (TTM) | 4.37 |
| EV/Revenue | 4.17 |
| EV/EBITDA | 18.90 |
| Quarterly Earnings Growth (YoY) | 16.60% |
| Quarterly Revenue Growth (YoY) | 26.50% |
| Shares Outstanding | $28.56M |
| Float | $23.01M |
| % Insiders | 19.39% |
| % Institutions | 86.91% |
Historical Volatility
HV 10-Day
135.16%
HV 20-Day
99.33%
HV 30-Day
83.05%
HV 60-Day
73.09%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($442.83 target)
1
Strong Buy3
Buy8
Hold1
SellData last updated: 4/29/2026